Filters
Use basic filters below or open advanced options for more precise results.
Last dataset refresh: 17 Apr 2026
| Product name | Classification | Strength | Form | Manufacturer | Country of origin | Status | Registered On | Action | |
|---|---|---|---|---|---|---|---|---|---|
|
illuma® 3
|
GSL Products | Combination | Powder | NESTLE SUISSE S.A, Switzerland, konolfingen | Switzerland | Active | 09 Jun 2022 | View details → | |
|
illuma® 3
|
GSL Products | Combination | Powder | NESTLE SUISSE S.A, Switzerland, konolfingen | Switzerland | Active | 09 Jun 2022 | View details → | |
|
Ilumya® 100 mg per ml
|
Biological Medicines | 100mg/1ml | Injection | HIKMA PHARMACEUTICALS, Jordan, Amman | Jordan | Active | 30 Jun 2022 | View details → | |
|
ILUVIEN®
|
Conventional Medicines | 0.19 mg/Implant | Implant | ALLIANCE MEDICAL PRPODUCTS, Inc. dba siegfried irvine, United States of America, Irvine | United States of America | Active | 07 Feb 2018 | View details → | |
|
Ima-Denk 100 mg
|
Conventional Medicines | 100 mg/tablet | Tablet | Haupt Pharma Amareg GmbH, Germany, Regensburg | Germany | Active | 29 Sep 2016 | View details → | |
|
Ima-Denk 400 mg
|
Conventional Medicines | 400 mg/tablet | Tablet | Haupt Pharma Amareg GmbH, Germany, Regensburg | Germany | Active | 29 Sep 2016 | View details → | |
|
IMADEV 400 mg
|
Conventional Medicines | 400 mg/Tablet | Tablet | DEVA HOLDING A.S, Turkey, Tekirdag | Turkey | Active | 06 Dec 2017 | View details → | |
|
Imalar 100 mg
|
Conventional Medicines | 100mg | Tablet | Sudair Pharma company, Saudi Arabia, Riyadh | Saudi Arabia | Active | 13 Apr 2020 | View details → | |
|
Imalar 400 mg
|
Conventional Medicines | 400mg | Tablet | Sudair Pharma company, Saudi Arabia, Riyadh | Saudi Arabia | Active | 13 Apr 2020 | View details → | |
|
Imatox® 4 mg
|
Conventional Medicines | 4mg/ tablet | Tablet | TABUK PHARMACEUTICAL MANUFACTURING CO., Saudi Arabia, Tabuk | Saudi Arabia | Active | 04 Feb 2021 | View details → | |
|
Imatox® 4 mg/2 ml
|
Conventional Medicines | 2 mg/ml | Injection or Infusion | Tabuk Pharmaceutical Manufacturing Co, Saudi Arabia, Dammam | Saudi Arabia | Active | 22 Oct 2020 | View details → | |
|
Imatox® 8 mg
|
Conventional Medicines | 8mg/tablet | Tablet | TABUK PHARMACEUTICAL MANUFACTURING CO., Saudi Arabia, Tabuk | Saudi Arabia | Active | 04 Feb 2021 | View details → | |
|
Imatox® 8 mg/4 ml
|
Conventional Medicines | 8mg /4ml | Injection or Infusion | Tabuk Pharmaceutical Manufacturing Co, Saudi Arabia, Dammam | Saudi Arabia | Active | 22 Oct 2020 | View details → | |
|
IMAVIR Cream
|
Conventional Medicines | 5% | Cream | Amman Pharmaceutical Industries Co. Ltd., Jordan, Amman | Jordan | Active | 26 May 2003 | View details → | |
|
IMAVIR Cream
|
Conventional Medicines | 5% | Cream | Amman Pharmaceutical Industries Co. Ltd., Jordan, Amman | Jordan | Active | 26 May 2003 | View details → | |
|
IMAVIR Sterile Ophthalmic Ointment
|
Conventional Medicines | 3% | Ointment | Amman Pharmaceutical Industries Co. Ltd., Jordan, Amman | Jordan | Active | 26 May 2003 | View details → | |
|
Imbrezo 0.25 mg/0.5 mL
|
Conventional Medicines | 0.25 mg/ 0.5 ml | Injection | GP-PHARM, S.A, Spain, Sant Quinti de Mediona (Barcelona) | Switzerland | Active | 26 May 2025 | View details → | |
|
Imbrezo 0.25 mg/0.5 mL
|
Conventional Medicines | 0.25 mg/ 0.5 ml | Injection | GP-PHARM, S.A, Spain, Sant Quinti de Mediona (Barcelona) | Switzerland | Active | 26 May 2025 | View details → | |
|
imbruvica™ 140 mg
|
Conventional Medicines | 140 mg/Tablet | Tablet | JANSSEN-CILAG S.p.A, Italy, LATINA | BELGIUM | Active | 15 May 2023 | View details → | |
|
imbruvica™ 420 mg
|
Conventional Medicines | 420 mg/Tablet | Tablet | JANSSEN-CILAG S.p.A, Italy, LATINA | BELGIUM | Active | 15 May 2023 | View details → | |
|
IMDYLLTRA® 1 mg
|
Biological Medicines | 1 mg/Vial | Infusion | AMGEN EUROPE B.V., Netherlands, Breda | United Kingdom | Active | 23 Apr 2025 | View details → | |
|
IMDYLLTRA® 10 mg
|
Biological Medicines | 10 mg/Vial | Infusion | AMGEN EUROPE B.V., Netherlands, Breda | United Kingdom | Active | 23 Apr 2025 | View details → | |
|
IMFERON Tablets
|
GSL Products | Combination | Tablet | Emil Pharmaceutical Industries Private Limited, India, Boisar | India | Active | 17 Feb 2025 | View details → | |
|
IMFINZI™ 120mg/2.4ml (50mg/ml)
|
Conventional Medicines | 50 mg/ml | Injection | AstraZeneca AB., Sweden, Sodertalje | United Kingdom | Active | 31 Dec 1999 | View details → |
Compare selected products
0 of 3 selected